1. Home
  2. MDXH vs CHCI Comparison

MDXH vs CHCI Comparison

Compare MDXH & CHCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • CHCI
  • Stock Information
  • Founded
  • MDXH 2003
  • CHCI 1985
  • Country
  • MDXH Belgium
  • CHCI United States
  • Employees
  • MDXH N/A
  • CHCI N/A
  • Industry
  • MDXH
  • CHCI Building operators
  • Sector
  • MDXH
  • CHCI Real Estate
  • Exchange
  • MDXH Nasdaq
  • CHCI Nasdaq
  • Market Cap
  • MDXH 73.3M
  • CHCI 68.9M
  • IPO Year
  • MDXH 2021
  • CHCI 2004
  • Fundamental
  • Price
  • MDXH $1.46
  • CHCI $8.96
  • Analyst Decision
  • MDXH Buy
  • CHCI
  • Analyst Count
  • MDXH 1
  • CHCI 0
  • Target Price
  • MDXH $6.00
  • CHCI N/A
  • AVG Volume (30 Days)
  • MDXH 88.1K
  • CHCI 35.7K
  • Earning Date
  • MDXH 04-30-2025
  • CHCI 03-21-2025
  • Dividend Yield
  • MDXH N/A
  • CHCI N/A
  • EPS Growth
  • MDXH N/A
  • CHCI 83.12
  • EPS
  • MDXH N/A
  • CHCI 1.41
  • Revenue
  • MDXH $90,049,000.00
  • CHCI $51,294,000.00
  • Revenue This Year
  • MDXH $23.38
  • CHCI N/A
  • Revenue Next Year
  • MDXH $16.84
  • CHCI N/A
  • P/E Ratio
  • MDXH N/A
  • CHCI $6.11
  • Revenue Growth
  • MDXH 28.29
  • CHCI 14.70
  • 52 Week Low
  • MDXH $1.35
  • CHCI $5.01
  • 52 Week High
  • MDXH $3.50
  • CHCI $14.48
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 36.94
  • CHCI 57.81
  • Support Level
  • MDXH $1.55
  • CHCI $8.28
  • Resistance Level
  • MDXH $1.66
  • CHCI $10.53
  • Average True Range (ATR)
  • MDXH 0.08
  • CHCI 0.97
  • MACD
  • MDXH 0.00
  • CHCI 0.23
  • Stochastic Oscillator
  • MDXH 21.84
  • CHCI 61.41

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About CHCI Comstock Holding Companies Inc.

Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.

Share on Social Networks: